Related Experiment Video
Updated: Jan 6, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Cardiovascular Risk Assessment in Renal and Liver Transplant Candidates: A Multidisciplinary Institutional
Donya Mohebali1, Anne-Marie Anagnostopoulos1, Alisson Estrada-Roman1
1From the Cardiology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA.
Insights
Transplant candidates increasingly have complex cardiovascular conditions, leading to higher mortality post-kidney transplant. This review establishes guidelines for cardiac testing to improve patient selection and reduce adverse cardiac events.
Area of Science:
- Cardiology
- Nephrology
- Hepatology
- Transplant Surgery
Background:
- Transplant candidates exhibit rising medical complexity, notably cardiovascular disease (CVD).
- CVD is the leading cause of death post-kidney transplant globally.
- Increasing end-stage liver disease from nonalcoholic steatohepatitis and higher MELD scores correlate with heightened CVD risk in liver transplant candidates.
Purpose of the Study:
- To review and establish clinical practice guidelines for cardiac testing in renal and liver transplant candidates.
- To standardize patient selection for cardiac evaluation.
- To reduce adverse cardiac events in the post-transplant period.
Main Methods:
- Multidisciplinary guideline development involving transplant nephrology, hepatology, surgery, and cardiology (general and interventional).
- Review of existing clinical practice guidelines and transplant center patterns.
- Focus on improving patient selection criteria for cardiac testing.
Main Results:
- Identified significant variation in current guidelines and practice patterns for cardiac testing in transplant candidates.
- Established a multidisciplinary approach to standardize cardiac evaluation protocols.
- Aimed to optimize the selection of patients requiring cardiac assessment.
Conclusions:
- Standardized, multidisciplinary guidelines are crucial for managing complex cardiovascular risk in transplant candidates.
- Improved patient selection for cardiac testing can mitigate post-transplant mortality.
- Adherence to established protocols can enhance outcomes for renal and liver transplant recipients.
Abstract:
In the modern era, renal and liver transplant candidates present with a greater medical complexity driven in part by a higher prevalence of cardiovascular conditions, including coronary artery disease, valvular heart disease, and cardiomyopathies. In fact, cardiovascular disease is the most common cause of death after kidney transplantation worldwide. Similarly, an increase in the number of patients being listed with end-stage liver disease from nonalcoholic steatohepatitis and a rising model for end-stage liver disease scores at the time of liver transplant in the United States parallel an increasing cardiovascular disease risk profile for liver transplant candidates. A large degree of variation exists among clinical practice guidelines and transplant center practice patterns regarding patient selection for routine cardiac testing and the choice of testing modalities. Here, we review the clinical practice guidelines established at our center by a multidisciplinary group, including transplant nephrology, hepatology, and surgery, as well as general and interventional cardiology, with the goal of improving patient selection and reducing adverse cardiac events posttransplant.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

